HIV: Pre-exposure Prophylaxis.
作者信息
Singh Ajai Kumar, Singh Ashish, Singh Deepti, Singh Manish, Singh Pratibha, Sharma Abhishek
机构信息
Department of Neurology, Dr. Ram Manohar Lohia Institute of Medical Sciences, Vibhooti Khand, Gomti Nagar, Lucknow, Uttar Pradesh, India.
出版信息
Int J Prev Med. 2012 Dec;3(12):900-1. doi: 10.4103/2008-7802.104864.
Abstract
摘要
相似文献
1
HIV: Pre-exposure Prophylaxis.人类免疫缺陷病毒：暴露前预防
Int J Prev Med. 2012 Dec;3(12):900-1. doi: 10.4103/2008-7802.104864.
2
What is the place of pre-exposure prophylaxis in HIV prevention?暴露前预防在艾滋病预防中的地位如何？
AIDS Rev. 2013 Apr-Jun;15(2):102-11.
3
Polarised press reporting about HIV prevention: Social representations of pre-exposure prophylaxis in the UK press.关于 HIV 预防的极化新闻报道：英国新闻界对暴露前预防的社会认知。
Health (London). 2017 Sep;21(5):478-497. doi: 10.1177/1363459316649763. Epub 2016 May 22.
4
A systematic review of adherence to oral pre-exposure prophylaxis for HIV - how can we improve uptake and adherence?系统评价口服暴露前预防 HIV 的依从性——我们如何提高使用率和依从性？
BMC Infect Dis. 2018 Nov 16;18(1):581. doi: 10.1186/s12879-018-3463-4.
5
Using a network-based approach and targeted maximum likelihood estimation to evaluate the effect of adding pre-exposure prophylaxis to an ongoing test-and-treat trial.使用基于网络的方法和目标最大似然估计来评估在正在进行的检测与治疗试验中添加暴露前预防的效果。
Clin Trials. 2017 Apr;14(2):201-210. doi: 10.1177/1740774516679666. Epub 2017 Jan 26.
6
Offering pre-exposure prophylaxis for HIV prevention to pregnant and postpartum women: a clinical approach.为预防艾滋病毒向孕妇和产后妇女提供暴露前预防：一种临床方法。
J Int AIDS Soc. 2017 Mar 8;20(Suppl 1):21295. doi: 10.7448/IAS.20.2.21295.
7
Does pre-exposure prophylaxis for HIV prevention in men who have sex with men change risk behaviour? A systematic review.男男性行为者的 HIV 预防暴露前预防是否会改变风险行为？系统评价。
J Clin Nurs. 2018 Sep;27(17-18):3254-3265. doi: 10.1111/jocn.13990.
8
HIV pre-exposure prophylaxis uptake by advanced practice nurses: Interplay of agency, community and attitudinal factors.高级执业护士对 HIV 暴露前预防措施的接受程度：机构、社区和态度因素的相互作用。
J Adv Nurs. 2019 Nov;75(11):2559-2569. doi: 10.1111/jan.14019. Epub 2019 Jul 30.
9
High incidence of HCV in HIV-negative men who have sex with men using pre-exposure prophylaxis.在使用暴露前预防药物的HIV阴性男男性行为者中丙型肝炎病毒（HCV）的高发病率。
J Hepatol. 2020 May;72(5):855-864. doi: 10.1016/j.jhep.2019.11.022. Epub 2019 Dec 18.
10
Has the introduction of HIV pre-exposure prophylaxis had an impact on HIV post-exposure prophylaxis for sexual exposure prescriptions in men who have sex with men in the UK's largest health board?在英国最大的卫生委员会中，暴露前预防措施的引入是否对男男性行为者因性接触开具的暴露后预防用药产生了影响？
Sex Transm Infect. 2018 Sep;94(6):462. doi: 10.1136/sextrans-2018-053734.
本文引用的文献
1
Size Estimation of Groups at High Risk of HIV/AIDS using Network Scale Up in Kerman, Iran.伊朗克尔曼市利用网络扩大法对艾滋病病毒/艾滋病高危群体进行规模估计
Int J Prev Med. 2012 Jul;3(7):471-6.
2
Microbicides for HIV prevention.用于艾滋病毒预防的杀微生物剂。
Indian J Med Res. 2011 Dec;134(6):930-8. doi: 10.4103/0971-5916.92638.
3
Pre-exposure prophylaxis of HIV.艾滋病病毒暴露前预防
Indian J Sex Transm Dis AIDS. 2011 Jan;32(1):1-8. doi: 10.4103/0253-7184.81246.
4
HIV/AIDS Counseling Skills and Strategies: Can Testing and Counseling Curb the Epidemic?《艾滋病毒/艾滋病咨询技巧与策略：检测与咨询能否遏制疫情？》
Int J Prev Med. 2011 Jan;2(1):10-4.
5
Microbicides & their implications in HIV prevention.杀微生物剂及其在艾滋病预防中的意义。
Indian J Med Res. 2010 Dec;132(6):656-9.
6
Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women.替诺福韦凝胶作为一种抗逆转录病毒的杀微生物剂，用于预防女性感染艾滋病毒的有效性和安全性。
Science. 2010 Sep 3;329(5996):1168-74. doi: 10.1126/science.1193748. Epub 2010 Jul 19.
7
In vitro and ex vivo testing of tenofovir shows it is effective as an HIV-1 microbicide.在体和离体实验证明替诺福韦可有效作为 HIV-1 杀微生物剂。
PLoS One. 2010 Feb 19;5(2):e9310. doi: 10.1371/journal.pone.0009310.
8
Is HIV drug resistance a limiting factor in the development of anti-HIV NNRTI and NRTI-based vaginal microbicide strategies?HIV耐药性是否是基于非核苷类逆转录酶抑制剂（NNRTI）和核苷类逆转录酶抑制剂（NRTI）的抗HIV阴道杀菌剂策略发展的限制因素？
Antiviral Res. 2006 Sep;71(2-3):343-50. doi: 10.1016/j.antiviral.2006.05.013. Epub 2006 Jun 9.
Zotero 插件